Medtronic’s OsteoCool™ Procedure Shows Significant, Swift Pain Relief and Sustained Improvement for Cancer Patients
- Tuesday, December 15, 2020, 7:14
- PR Newswire
- Add a comment
DUBLIN, Dec. 15, 2020 /PRNewswire/ — Medtronic plc (NYSE: MDT) today announced the release of outcomes in the first 100 patients treated with the OsteoCool™ Radiofrequency Ablation (RFA) System in the OPuS One Clinical Study (as referenced below) – the largest, prospective study in RFA…
About the Author
admin has written 21803 stories on this site.